Same Indication

Lansoprazole vs Pembrolizumab

Lansoprazole vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between Lansoprazole and Pembrolizumab.

Mechanism of Action

Lansoprazole: Proton pump inhibitor.

Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

Pharmacokinetics

Half-life: Lansoprazole — 1.5 hours; Pembrolizumab — 26 days.

Chemical Properties

Molecular Formula: Lansoprazole — C16H14F3N3O2S.

Molecular Weight: Lansoprazole — 369.3620 g/mol.

Type: Lansoprazole — Small molecule; Pembrolizumab — Antibody.